《柳葉刀》艾滋病毒于2014年9月作為一份獨(dú)家在線雜志發(fā)行，出版原創(chuàng)研究、專(zhuān)家評(píng)論、內(nèi)容豐富的社論和及時(shí)通信。該月刊為讀者提供了背景和洞察的臨床進(jìn)展和實(shí)踐變化的研究塑造了今天的艾滋病毒/艾滋病的研究。按照《柳葉刀》的傳統(tǒng)，該雜志經(jīng)過(guò)嚴(yán)格編輯和同行評(píng)審，以確?？茖W(xué)價(jià)值和臨床相關(guān)性。所有的原創(chuàng)研究都將在提交后8周內(nèi)接受同行評(píng)審，并通過(guò)我們的在線平臺(tái)thelancet.com和ScienceDirect在全球范圍內(nèi)接觸醫(yī)學(xué)艾滋病毒/艾滋病社區(qū)。選擇具有高影響力的研究,《華爾街日?qǐng)?bào)》新聞辦公室致力于促進(jìn)世界范圍內(nèi)的媒體報(bào)道,確保廣泛的全球接觸你的研究。

The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.